Heparin-like polysaccharides markedly reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

被引：0
|
作者：
Kakonen, R. S. [1 ]
Kakonen, S. [2 ]
Mohammad, K. S. [3 ]
Rissanen, J. P. [1 ]
Halleen, J. M. [1 ]
Warri, A. [4 ]
Nissinen, L. [4 ]
Pihlavisto, M. [4 ]
Chirgwin, J. M. [3 ]
Salmivirta, M. [5 ]
Marjamaki, A. [4 ]
Guise, T. A. [3 ]
机构：
[1] Pharmatest Serv Ltd, Turku, Finland
[2] Univ Turku, Dept Anat, SF-20500 Turku, Finland
[3] Univ Virginia, Charlottesville, VA 22903 USA
[4] BioTie Therapies Corp, Turku, Finland
[5] Turku Ctr Biotechnol, Turku, Finland
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
T241
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [41] Metastatic Breast Cancer Cells Induce Osteocyte Senescence Contributing to Osteolytic Bone Destruction
    Kaur, Japneet
    Adhikari, Manish
    Sabol, Hayley
    Anloague, Aric
    Khan, Sharmin
    Barnes, Lowry
    Stambough, Jeffrey
    Palmieri, Michela
    Reyes-Castro, Olivia
    Ambrogini, Elena
    Almeida, Maria Jose
    O'Brien, Charles
    Nookaew, Intawat
    Delgado-Calle, Jesus
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 1 - 1
  • [42] Accelerated bone resorption promotes tumour growth in a murine model of breast cancer bone metastasis
    Zheng, Y.
    Zhou, H.
    Modzelewski, J. R. K.
    Kalak, R.
    Blair, J. M.
    Seibel, M. J.
    Dunstan, C. R.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S39 - S40
  • [43] The Prognostic Factors for Tumor Metastasis to Bone from Breast Cancer and Survival for Breast Cancer Patients after Bone Metastasis
    Ahn, Sung Gui
    Sik-Lee, Knng
    Kim, Seung Il
    JOURNAL OF BREAST CANCER, 2008, 11 (04) : 187 - 193
  • [44] ZK-EPO, a third-generation epothilone inhibits tumor growth and osteolysis in a mouse model of breast cancer bone metastasis
    Kakonen, S.
    Hoffmann, J.
    Klar, U.
    ANNALS OF ONCOLOGY, 2007, 18 : 35 - 35
  • [45] Mouse model of human breast cancer metastasis to tissue engineered bone scaffolds
    Moreau, J. E.
    Mauney, J. R.
    Anderson, K.
    Nguyen, T. T.
    Kaplan, D. L.
    Rosenblatt, M.
    CANCER TREATMENT REVIEWS, 2006, 32 : S42 - S42
  • [46] Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer
    Halvorson, Kyle G.
    Sevcik, Molly A.
    Ghilardi, Joseph R.
    Rosol, Thomas J.
    Mantyh, Patrick W.
    CLINICAL JOURNAL OF PAIN, 2006, 22 (07): : 587 - 600
  • [47] 1,25(OH)2D3 deficiency increases TM40D tumor growth in bone and accelerates tumor-induced bone destruction in a breast cancer bone metastasis model
    Lu, Guangping
    Li, Jun
    Chu, Jiahui
    Jin, Shidai
    Fu, Ziyi
    Miao, Dengshun
    Yin, Yongmei
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 1033 - 1039
  • [48] Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis
    Jude R. Canon
    Martine Roudier
    Rebecca Bryant
    Sean Morony
    Marina Stolina
    Paul J. Kostenuik
    William C. Dougall
    Clinical & Experimental Metastasis, 2008, 25 : 119 - 129
  • [49] GROWTH AND OSTEOLYTIC BONE METASTASIS OF HUMAN BREAST-CANCER IS DEPENDENT ON THEIR SRC TYROSINE KINASE (TK) ACTIVITY
    NIEWOLNA, M
    NISHIMURA, R
    WILLIAMS, P
    DUNSTAN, C
    ADAMS, R
    SASAKI, A
    MUNDY, GR
    YONEDA, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S177 - S177
  • [50] Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis
    Canon, Jude R.
    Roudier, Martine
    Bryant, Rebecca
    Morony, Sean
    Stolina, Marina
    Kostenuik, Paul J.
    Dougall, William C.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (02) : 119 - 129
12345